abstract |
The invention relates to a dermal therapeutic system which enables a constant delivery of a COX-2 inhibitor to the skin and the adjacent joint structures over a longer period of time. The Dermal Therapeutic System can be either a Transdermal Therapeutic System (TTS) or a Superficial Therapeutic System (STS). |